8.330CADMkt Cap: 817.83M CADP/E: 138.83Last update: 2026-05-21
Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America. The company offers Minjuvi for relapsed or refr…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 168.3
54.96BEURP/E 21.7
52.53BTRYP/E 27.3
33.63BPLNP/E 21.9
13.36BSEKP/E 40.3
13.24BEURP/E 30.2
12.58BTRY—
3.96BUSDP/E 33.6
loading…
Indicators:|
Key Statistics
Company
Market Cap817.83M CAD
Enterprise Value744.43M CAD
Revenue (TTM)510.45M CAD
Gross Profit200.23M CAD
Net Income (TTM)-5.37M CAD
Revenue/Share5.142 CAD
Last Price8.330 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees830
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)138.83
P/E (Forward)30.85
PEG—
EV/EBITDA10.62
EV/Revenue1.46
P/S1.60
P/B1.04
EPS (TTM)0.06
EPS (Forward)0.27
52W Range
8.14086% of range8.360
52W High8.360 CAD
52W Low8.140 CAD
Profitability
Gross Margin44.49%
Oper. Margin7.13%
EBITDA Margin13.74%
Profit Margin-1.19%
ROE-0.70%
ROA-0.51%
Growth
Revenue Growth68.50%
Earnings Growth550.00%
Cash Flow & Leverage
Operating CF68.96M CAD
CapEx (TTM)33.69M CAD
FCF Margin13.01%
FCF Yield8.12%
Net Debt-73.41M CAD
Net Debt/EBITDA-1.05
Balance Sheet
Debt/Equity0.10
Current Ratio2.32
Quick Ratio1.56
Book Value/Sh8.013 CAD
Cash/Share1.458 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)9.393 CAD
Target Range7.450 CAD – 12.00 CAD
# Analysts7
Ownership
Shares Out.98.18M
Float60.26M
Insiders46.95%
Institutions20.06%
Short Interest
Short Ratio32.3d
Short % Out.1.90%
Shares Short1.91M
Short (prev mo.)1.95M
Technical
SMA 507.452 (+11.8%)
SMA 2006.428 (+29.6%)
Beta0.04
S&P 52W Chg28.31%
Avg Vol (30d)29.52K
Avg Vol (10d)145.93K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—